3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasms
6
Melanoma
3
Head and Neck Neoplasms
3
Lymphedema
2
Breast Neoplasms
2
Xeroderma Pigmentosum
1
Uterine Cervical Neoplasms
1
Trichothiodystrophy Syndromes
1
Signs and Symptoms, Digestive
1
Sexuality
1
Pelvic Organ Prolapse
1
Papillomavirus Infections
1
Pain
1
Nasopharyngeal Carcinoma
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leiomyoma
1
Hematologic Neoplasms
1
HIV Infections
1
Genetic Diseases, Inborn
1
Fibrosis
1
Epstein-Barr Virus Infections
1
Endometrial Neoplasms
1
Endometrial Hyperplasia
1
Depression
1
DNA Repair-Deficiency Disorders
1
Colorectal Subepithelial Lesions
1
Cockayne Syndrome
1
Cicatrix
1
Interventions
Surveys and Questionnaires
7
Interviews as Topic
7
Blood Specimen Collection
5
Specimen Handling
4
Exercise Test
4
fludarabine
3
Voriconazole
3
Mental Status and Dementia Tests
3
Bortezomib
3
Standard of Care
2
Observation
2
Itraconazole
2
Flow Cytometry
2
Electronic Health Records
2
Data Collection
2
Antiviral Agents
2
posaconazole
1
liposomal amphotericin B
1
isavuconazole
1
glucarpidase
1
fludarabine phosphate
1
brexucabtagene autoleucel
1
axicabtagene ciloleucel
1
Whole-Body Irradiation
1
Watchful Waiting
1
Vincristine
1
Valganciclovir
1
Transplantation
1
Tomography, X-Ray Computed
1
Tomography, Optical Coherence
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Hematologic Neoplasms
×
Restraint, Physical
×
Clear all
NCT02824159
2020-12-28
PK-E3I
University Hospital, Toulouse
Completed
121 enrolled